INVESTORS & MEDIA
Corporate Governance
Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
---|---|---|---|---|---|---|---|
Mar 24, 2014 |
Director
Trans History: 282
|
Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 15,000 | $23.84 | 24,000 |
Mar 24, 2014 |
Director
Trans History: 282
|
Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 15,000 | -- | -- |
Feb 14, 2014 |
Director
Trans History: 320
|
Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 15,000 | $9.17 | 127,772 |
Feb 14, 2014 |
Director
Trans History: 320
|
Director | Form 4 | Open market or private sale of non-derivative or derivative security | 15,000 | $324.00 | 112,772 |
Feb 14, 2014 |
Director
Trans History: 320
|
Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 15,000 | -- | -- |
Dec 13, 2013 |
SVP Administration & Asst Secr
Trans History: 645
|
SVP Administration & Asst Secr | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 15,000 | -- | 15,000 |
Sep 30, 2013 |
Director
Trans History: 282
|
Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 15,000 | $19.69 | 24,000 |
Sep 30, 2013 |
Director
Trans History: 282
|
Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 15,000 | -- | -- |
Sep 18, 2013 |
VP Reg Dev & Med Safety
Trans History: 288
|
VP Reg Dev & Med Safety | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 15,000 | $16.80 | 35,644 |
Sep 18, 2013 |
VP Reg Dev & Med Safety
Trans History: 288
|
VP Reg Dev & Med Safety | Form 4 | Open market or private sale of non-derivative or derivative security | 15,000 | $304.00 | 20,644 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.